Eosinophilia myalgia syndrome. The role of contaminants, the role of serotonergic metabolism set up.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  PMID 8906288
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolism and distribution in the rat of peak E substance, a constituent inl-tryptophan product implicated in eosinophilia-myalgia syndrome

  2005cited by this paper
• 5-Hydroxytryptamine supersensitivity as a new theory of headache and central pain: A clinical pharmacological approach with p-chlorophenylalanine

  2004cited by this paper
• Production of polyclonal antibodies against 1,1'-ethyliden bis[L-tryptophan] (EBT), a potential contaminant causing eosinophilia-myalgia syndrome (EMS).

  1993cited by this paper
• Eosinophilia‐myalgia syndrome: lessons for public health researchers

  1993cited by this paper
• L-tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis.

  1993cited by this paper
• Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico.

  1993cited by this paper
• Chronic immune activation in the eosinophiliamyalgia syndrome

  1993cited by this paper
• Demyelinating polyneuropathy in eosinophilia–myalgia syndrome

  1992cited by this paper
• 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?

  1992cited by this paper
• The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.

  1990cited by this paper
• Kynurenic acid is present in the rat brain and its content increases during development and aging processes.

  1988cited by this paper
• L-5HTP Treatment in Primary Headaches: An Attempt at Clinical Identification of Responsive Patients

  1984cited by this paper
• The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain.

  1984cited by this paper
• Impaired 5-Hydroxytryptamine Tachyphylaxis in Migraine

  1983cited by this paper
• Systemic Non‐Organic Central Pain: A New Syndrome with Decentralization Supersensitivity

  1978cited by this paper
• Plasma tryptophan and musculoskeletal pain in non‐articular rheumatism (“fibrositis syndrome”)

  1978cited by this paper
• Studies on the antagonism by raphe lesions of the antinociceptive action of systemic morphine.

  1977cited by this paper
• Interaction of diet and drugs in the regulation of brain 5-hydroxyindoles and the response to painful electric shock.

  1976cited by this paper
• THE INGESTION OF SEROTONIN PRECURSORS (L‐5‐HYDROXYTRYPTOPHAN AND L‐TRYPTOPHAN) IMPROVES MIGRAINE HEADACHE

  1973cited by this paper
• Free Tryptophan in Plasma and Brain Tryptophan Metabolism

  1972cited by this paper
• Effect of serotonin in migraine patients

  1960cited by this paper

• 5-Hydroxytryptophan

  2020cites this paper